sorafenib has been researched along with Degenerative Diseases, Central Nervous System in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chou, CW; Huang, YK; Kuo, TT; Liu, JP; Sher, YP | 1 |
| Burgess, S; Echeverria, V | 1 |
2 review(s) available for sorafenib and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
An Overview of ADAM9: Structure, Activation, and Regulation in Human Diseases.
Topics: ADAM Proteins; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Membrane Proteins; Neoplasms; Neurodegenerative Diseases; Phenylurea Compounds; Pyridines; Retinal Diseases; Sorafenib; Tumor Microenvironment | 2020 |
Raf inhibitors as therapeutic agents against neurodegenerative diseases.
Topics: Animals; Benzenesulfonates; Brain; Disease Models, Animal; Drug Design; Encephalitis; Humans; Inflammation Mediators; Neurodegenerative Diseases; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-raf; Pyridines; Signal Transduction; Sorafenib | 2010 |